MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,083,736 | -41.5% | 631,520 | -21.1% | 0.06% | -41.7% |
| Q2 2023 | $8,688,000 | -21.2% | 800,000 | -49.9% | 0.10% | -31.3% |
| Q1 2023 | $11,022,136 | +44.1% | 1,597,411 | -16.9% | 0.15% | +45.6% |
| Q4 2022 | $7,647,140 | -33.1% | 1,921,392 | +11.8% | 0.10% | -35.6% |
| Q3 2022 | $11,426,000 | – | 1,718,123 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $41,305,000 | 7.74% |
| VR Adviser, LLC | 2,641,809 | $30,064,000 | 3.86% |
| Bleichroeder LP | 1,062,500 | $12,091,000 | 1.96% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $16,285,000 | 1.01% |
| Boxer Capital, LLC | 2,400,000 | $27,312,000 | 0.95% |
| 683 Capital Management, LLC | 1,929,929 | $21,963,000 | 0.86% |
| Avoro Capital Advisors LLC | 3,235,000 | $36,814,000 | 0.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,197,426 | $25,007,000 | 0.42% |
| Granite Point Capital Management, L.P. | 419,324 | $4,772,000 | 0.36% |
| KNOTT DAVID M | 81,166 | $924,000 | 0.34% |